Percutaneous transcatheter occlusion of atrial septal defects (ASD) and patent foramen
ovale (PFO) is less invasive than the gold standard of surgical closure [1]. Indications for this …

Transesophageal echocardiography (TEE) has been employed successfully for guiding
transcatheter device closure of secundum atrial septal defect (ASD) and patent foramen …

Atrial septal defect (ASD) is a common congenital defect (1 in 1000 live births) and accounts
for up to 40% of clinically relevant acyanotic shunts in adults. 1 Patent foramen ovale (PFO) …

Percutaneous device closure is now the method of choice for ASD [1] and PFO [2] closure,
but success remains imperfect [1, 2] despite the wide range of devices available, and …

In 2001, the US Food and Drug Administration approved the use of septal occluder devices
for closing atrial septal defects and patent foramen ovale (PFO). Soon, many tertiary centers …

Intracardiac echocardiography is the newest imaging technology permitting whole-heart
evaluation from a right-sided catheter position and contrast transcranial Doppler is an ideal …

Objectives To describe our experience with intracardiac echocardiographic (ICE) guidance
during transcatheter device closure of atrial septal defect (ASD) and patent foramen ovale …

Transcatheter closure of atrial septal defects and patent foramen ovale has become
increasingly common with advances in device and imaging technology. The percutaneous …

High-quality imaging of the atrial septum has never been so relevant to the adult
cardiologist. This article focuses on the role of echocardiography in the evaluation of patent …

Transesophageal echocardiography (TEE) has been successfully used for guiding
transcatheter device closure of secundum atrial septal defect (ASD) and patent foramen …